Work

Comparison of pharmacokinetic properties of mitomycin C-based regimens for hyperthermic intraperitoneal chemotherapy in a rat model

Year: 2026
Type: article
Abstract: Mitomycin-C (MMC) is the most widely used agent for hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal peritoneal metastases, though dosing and intervals vary across institutions. This study aimed to compare the pharmacokinetic profiles of three MMC-based HIPEC regimens. Eighteen male Sprague–Dawley rats were randomized into three groups for 90 min of HIPEC at 41–42℃. Group 1 received 35 mg/m² in three divided doses at 0, 30, and 60 min; Group 2 received 40 mg/m² in two divided doses at 0 and 60 min; Group 3 received a single bolus dose of 35 mg/m² at HIPEC initiation. Peritoneal fluid and plasma concentrations were measured by liquid chromatography-tandem mass spectrometry. MMC concentrations differed significantly across groups over the 90-minute perfusion period ( p < 0.001). Peritoneal concentrations at 90 min were comparable among groups (73.63 vs. 75.92 and 79.58 ng/mL), whereas the plasma concentration was lower in Group 1 (1.59 vs. 2.45 and 2.02 ng/mL; p = 0.043). The peritoneal-to-plasma AUC ratios were comparable among groups (52.1 vs. 47.7 vs. 47.1, respectively; p = 0.849). In conclusion, the three MMC-based HIPEC protocols showed no significant differences in the peritoneal-to-plasma AUC ratio, although Group 1 demonstrated lower plasma MMC concentrations.
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W7168268273
FWCI:
Cites: 31
Cited by:
Related to: 10